COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) (AIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02471391
Recruitment Status : Unknown
Verified June 2015 by Peter MacCallum Cancer Centre, Australia.
Recruitment status was:  Recruiting
First Posted : June 15, 2015
Last Update Posted : August 31, 2015
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2017
Estimated Study Completion Date : June 2018